Keywords
Hereditary angioedema
C1-INH protein
Edema
Diagnosis
ELISA
Public health
How to Cite
Abstract
OBJECTIVE: To establish, at the first time in Paraguay, for the first time in Paraguay, the laboratory diagnosis of HAE and to characterize affected patients.
METHODS: An observational, descriptive, and cross-sectional study was conducted from 2023 to 2024 in patients older than one year with clinical symptoms of hereditary angioedema and asymptomatic relatives registered with the AEH-Paraguay Association, and 20 healthy donors. Quantitative C1-INH was determined by radial immunodiffusion and functional C1-INH by ELISA. Clinical and sociodemographic characteristics were evaluated.
RESULTS: Forty patients were included: 26 with clinical symptoms of hereditary angioedema and 14 asymptomatic relatives. Fifty-three percent (21/40) were female, and 15/40 were minors (1–16 years). Decreased quantitative and functional C1-INH levels (HAE-1) were observed in 21/40 patients, and decreased functional C1-INH levels (HAE-2) were observed in 4/40. In this group (n = 25), 20 had edema and 5 were asymptomatic relatives; in addition, 6 patients in this group had a previous laboratory diagnosis, and 19 were newly detected cases. The most frequent edemas appeared in the extremities, face, abdomen, and larynx (n = 9). Fifty-six percent (14/25) reported having a deceased relative with a history of edema. Stress and puberty were the main triggering factors, and the median age of onset was 13 years. Six patients reported prophylactic treatment; the median duration of edema-related crises at one year was 6, with a median of 14 days of disability.
CONCLUSION: We studied C1-INH in patients with recurrent edema and asymptomatic relatives, detecting 19 new cases and characterizing 25 patients with hereditary angioedema. This is the first diagnostic approach in Paraguay, and we report these initial data, which may be useful for the public health system in developing policies that address the diagnosis and treatment of patients with hereditary angioedema.
KEYWORDS: Paraguay; Hereditary angioedema; C1-INH protein; Edema; Diagnosis; ELISA; Public health.
References
1. Maurer M, Magerl M, Betschel S, et al. The international WAO/EAACI guideline for the management of hereditary angioedema—The 2021 revision and update. Eur J Allergy Clin Immunol. 2022; 77 (7): 1961-1990. doi:10.1111/all.15214
2. de Maat S, Joseph K, Maas C, Kaplan AP. Blood Clotting and the Pathogenesis of Types I and II Hereditary Angioedema. Clin Rev Allergy Immunol. 2021; 60 (3): 348-356. doi:10.1007/s12016-021-08837-6
3. Maas C, López-Lera A. Hereditary Angioedema: Insights into inflammation and allergy. Mol Immunol. 2019; 112: 378-386. doi:10.1016/j.molimm.2019.06.017
4. Cicardi M, Zuraw BL. Angioedema Due to Bradykinin Dysregulation. J Allergy Clin Immunol Pract. 2018; 6 (4): 1132-1141. doi:10.1016/j.jaip.2018.04.022
5. Ponard D, Gaboriaud C, Charignon D, et al. SERPING1 mutation update: Mutation spectrum and C1 Inhibitor phenotypes. Hum Mutat. 2020; 41 (1): 38-57. doi:10.1002/humu.23917
6. Lumry WR, Settipane RA. Hereditary angioedema: Epidemiology and burden of disease. Allergy Asthma Proc. 2020; 41 (6): S8-S13. doi:10.2500/AAP.2020.41.200050
7. Nowicki RJ, Grubska-Suchanek E, Porębski G, et al. Angioedema. Interdisciplinary diagnostic and therapeutic recommendations of the Polish Dermatological Society (PTD) and Polish Society of Allergology (PTA). Przegl Dermatol. 2020; 107 (4): 293-307. doi:10.5114/dr.2020.99875
8. Lai Y, Zhang G, Inhaber N, et al. A robust multiplexed assay to quantify C1-inhibitor, C1q, and C4 proteins for in vitro diagnosis of hereditary angioedema from dried blood spot. J Pharm Biomed Anal. 2021; 195. doi:10.1016/j.jpba.2020.113844
9. Vázquez DO, Josviak DO, Fantini CA, et al. Consenso argentino de diagnóstico y tratamiento del angioedema hereditario. Rev Alerg México. 2021; 68 (6): s1-s22. doi:10.29262/ram.v68i6.914
10. Betschel S, Badiou J, Binkley K, et al. The International/Canadian Hereditary Angioedema Guideline. Allergy, Asthma Clin Immunol. 2019; 15 (1): 1-29. doi:10.1186/s13223-019-0376-8
11. Zuraw BL, Bork K, Bouillet L, et al. Hereditary Angioedema with Normal C1 Inhibitor: an Updated International Consensus Paper on Diagnosis, Pathophysiology, and Treatment. Clin Rev Allergy Immunol. 2025; 68 (1). doi:10.1007/s12016-025-09027-4
12. Sinnathamby ES, Issa PP, Roberts L, et al. Hereditary Angioedema: Diagnosis, Clinical Implications, and Pathophysiology. Adv Ther. 2023; 40 (3): 814-827. doi:10.1007/s12325-022-02401-0
13. Li HH, Busse P, Lumry WR, et al. Comparison of Chromogenic and ELISA Functional C1 Inhibitor Tests in Diagnosing Hereditary Angioedema. J Allergy Clin Immunol Pract. 2015; 3 (2): 200-205. doi:10.1016/j.jaip.2014.08.002
14. Manning ME. Hereditary angioedema: Differential diagnosis, diagnostic tests, and family screening. Allergy Asthma Proc. 2020; 41 (6): S22-S25. doi:10.2500/aap.2020.41.200062
15. Nordenfelt P, Nilsson M, Björkander J, Mallbris L, et al. Hereditary Angioedema in Swedish Adults: Report From the National Cohort. Acta Derm Venereol. 2016;96(4):540-545. doi:10.2340/00015555-2274
16. Heidi Zafra M. Hereditary Angioedema: A Review. Wis Med J. 2022; 121 (1): 48-53.
17. Henao MP, Craig T, Kraschnewski J, Kelbel T. Diagnosis and screening of patients with hereditary angioedema in primary care. Ther Clin Risk Manag. 2016; 12: 701-711. doi:10.2147/TCRM.S86293
18. Santacroce R, D’Andrea G, Maffione AB, Margaglione M, D’Apolito M. The Genetics of Hereditary Angioedema: A Review. J Clin Med. 2021; 10 (9). doi:10.3390/jcm10092023
19. Grumach AS, Gadir N, Kessel A, Yegin A, et al. Current challenges and future opportunities in patient‐focused management of hereditary angioedema: A narrative review. Clin Transl Allergy. 2023; 13 (5). doi:10.1002/clt2.12243
20. Busse PJ, Christiansen SC. Hereditary Angioedema. N Engl J Med. 2020; 382 (12): 1136-1148. doi:10.1056/NEJMra1808012
21. Rosi-Schumacher M, Shah SJ, Craig T, Goyal N. Clinical manifestations of hereditary angioedema and a systematic review of treatment options. Laryngoscope Investig Otolaryngol. 2021; 6 (3): 394-403. doi:10.1002/lio2.555
22. Giavina-Bianchi P, Arruda LK, Aun M V. et al. Brazilian guidelines for hereditary angioedema management - 2017 update part 1: Definition, classification and diagnosis. Clinics. 2018; 73: 5-9. doi:10.6061/clinics/2018/e310
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2026 Revista Alergia México